NO158941C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.Info
- Publication number
- NO158941C NO158941C NO843117A NO843117A NO158941C NO 158941 C NO158941 C NO 158941C NO 843117 A NO843117 A NO 843117A NO 843117 A NO843117 A NO 843117A NO 158941 C NO158941 C NO 158941C
- Authority
- NO
- Norway
- Prior art keywords
- piperidino
- preparation
- therapeutic active
- analogy procedure
- chinazoline derivatives
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838320958A GB8320958D0 (en) | 1983-08-03 | 1983-08-03 | Quinazoline cardiac stimulants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO843117L NO843117L (no) | 1985-02-04 |
| NO158941B NO158941B (no) | 1988-08-08 |
| NO158941C true NO158941C (no) | 1988-11-16 |
Family
ID=10546755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO843117A NO158941C (no) | 1983-08-03 | 1984-08-02 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4542132A (cs) |
| EP (1) | EP0135318B1 (cs) |
| JP (1) | JPS6069081A (cs) |
| KR (1) | KR870000905B1 (cs) |
| AU (1) | AU555482B2 (cs) |
| CS (1) | CS253714B2 (cs) |
| DD (1) | DD223452A5 (cs) |
| DE (1) | DE3472677D1 (cs) |
| DK (1) | DK375584A (cs) |
| ES (1) | ES8507536A1 (cs) |
| FI (1) | FI843047A (cs) |
| GB (1) | GB8320958D0 (cs) |
| GR (1) | GR82659B (cs) |
| HU (1) | HUT37421A (cs) |
| IL (1) | IL72562A (cs) |
| NO (1) | NO158941C (cs) |
| NZ (1) | NZ209095A (cs) |
| PH (1) | PH20835A (cs) |
| PL (1) | PL249025A1 (cs) |
| PT (1) | PT79001B (cs) |
| YU (1) | YU135884A (cs) |
| ZA (1) | ZA845944B (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| FR2582513B1 (fr) * | 1985-05-28 | 1988-08-05 | Synthelabo | Compositions pharmaceutiques contenant de l'alfuzosine |
| US5614627A (en) * | 1993-09-10 | 1997-03-25 | Eisai Co., Ltd. | Quinazoline compounds |
| US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| US7825244B2 (en) * | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
| JP2009213594A (ja) * | 2008-03-10 | 2009-09-24 | Okamura Chikuzai:Kk | 葬祭用祭壇装置 |
| CN104860870A (zh) * | 2014-02-26 | 2015-08-26 | 欧美嘉股份有限公司 | 具有不同取代基的哌啶的制备方法 |
| EP4097089A4 (en) * | 2020-01-31 | 2024-02-28 | Trinapco, Inc | TRIFLAZOLES AND THEIR PRODUCTION PROCESS |
| US11294401B2 (en) | 2020-07-08 | 2022-04-05 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11314266B2 (en) | 2020-07-08 | 2022-04-26 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11131158B1 (en) | 2020-07-08 | 2021-09-28 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11256273B2 (en) | 2020-07-08 | 2022-02-22 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11802645B2 (en) | 2020-07-08 | 2023-10-31 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11274501B2 (en) | 2020-07-08 | 2022-03-15 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| US4101548A (en) * | 1977-02-22 | 1978-07-18 | Bristol-Myers Company | 1,2,3-Thiadiazole amides |
| IN148482B (cs) * | 1977-06-03 | 1981-03-07 | Pfizer | |
| US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
| US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
| US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
-
1983
- 1983-08-03 GB GB838320958A patent/GB8320958D0/en active Pending
-
1984
- 1984-07-30 PT PT79001A patent/PT79001B/pt unknown
- 1984-07-30 EP EP84305151A patent/EP0135318B1/en not_active Expired
- 1984-07-30 DE DE8484305151T patent/DE3472677D1/de not_active Expired
- 1984-07-31 GR GR75460A patent/GR82659B/el unknown
- 1984-07-31 JP JP59161498A patent/JPS6069081A/ja active Pending
- 1984-07-31 US US06/636,197 patent/US4542132A/en not_active Expired - Lifetime
- 1984-08-01 IL IL72562A patent/IL72562A/xx unknown
- 1984-08-01 DD DD84265888A patent/DD223452A5/de unknown
- 1984-08-01 ZA ZA845944A patent/ZA845944B/xx unknown
- 1984-08-01 PL PL24902584A patent/PL249025A1/xx unknown
- 1984-08-01 FI FI843047A patent/FI843047A/fi not_active Application Discontinuation
- 1984-08-01 YU YU01358/84A patent/YU135884A/xx unknown
- 1984-08-01 PH PH31057A patent/PH20835A/en unknown
- 1984-08-02 NZ NZ209095A patent/NZ209095A/xx unknown
- 1984-08-02 KR KR1019840004616A patent/KR870000905B1/ko active IP Right Grant
- 1984-08-02 HU HU842948A patent/HUT37421A/hu unknown
- 1984-08-02 DK DK375584A patent/DK375584A/da not_active Application Discontinuation
- 1984-08-02 NO NO843117A patent/NO158941C/no unknown
- 1984-08-02 ES ES534824A patent/ES8507536A1/es not_active Expired
- 1984-08-02 AU AU31419/84A patent/AU555482B2/en not_active Ceased
- 1984-08-03 CS CS845918A patent/CS253714B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK375584A (da) | 1985-02-04 |
| DD223452A5 (de) | 1985-06-12 |
| FI843047A (fi) | 1985-02-04 |
| IL72562A0 (en) | 1984-11-30 |
| YU135884A (en) | 1986-10-31 |
| CS253714B2 (en) | 1987-12-17 |
| ES534824A0 (es) | 1985-09-01 |
| DK375584D0 (da) | 1984-08-02 |
| ES8507536A1 (es) | 1985-09-01 |
| AU555482B2 (en) | 1986-09-25 |
| AU3141984A (en) | 1985-02-07 |
| NO158941B (no) | 1988-08-08 |
| FI843047A0 (fi) | 1984-08-01 |
| EP0135318A1 (en) | 1985-03-27 |
| PT79001B (en) | 1986-10-23 |
| EP0135318B1 (en) | 1988-07-13 |
| CS591884A2 (en) | 1987-05-14 |
| KR870000905B1 (ko) | 1987-05-04 |
| NO843117L (no) | 1985-02-04 |
| US4542132A (en) | 1985-09-17 |
| PT79001A (en) | 1984-08-01 |
| ZA845944B (en) | 1986-07-30 |
| IL72562A (en) | 1987-03-31 |
| PH20835A (en) | 1987-04-30 |
| GB8320958D0 (en) | 1983-09-07 |
| NZ209095A (en) | 1986-11-12 |
| JPS6069081A (ja) | 1985-04-19 |
| KR850001746A (ko) | 1985-04-01 |
| DE3472677D1 (de) | 1988-08-18 |
| PL249025A1 (en) | 1985-08-27 |
| GR82659B (cs) | 1985-02-07 |
| HUT37421A (en) | 1985-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163451C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater. | |
| NO162764C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater. | |
| NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
| NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO165192C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
| NO841568L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO156864C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO164301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. | |
| NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
| NO164169C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater. | |
| NO159930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater. | |
| NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
| NO161559C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
| NO161738C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater. | |
| NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
| NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
| NO160512C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO161800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler. |